English | Español

Boehringer Ingelheim Pharmaceuticals, Inc.
Mark Iandolo | Oct 19, 2016

Boehringer Ingelheim to provide treatment option for Leukemia Society's Beat AML initiative

Trending
Patient Daily | Jul 8, 2025

Clinical assistant professor at Stanford: ‘Musical background is associated with better performance of fundamental surgical skills'
Patient Daily | Jul 9, 2025

FDA approves Longeveron's Phase 2 study for pediatric dilated cardiomyopathy treatment